未登录

D

Dadi Zeng

Henan University

H指数:6

被引数:104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disrupting IL-11/IL-11R signaling by an efficacious anti-IL-11 antibody 9MW3811 enhances T cell tumor infiltration and synergizes with anti-PD-1 therapies in vivo

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

对SARS-CoV-2和传染性非典型肺炎具有交叉中和活性的人单克隆抗体MW06的表征

IF7.3

2021-07-2722

OAAI

A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2019-01-137

OAAI

A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety

IF3

2018-08-0119

PREAI

A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus

具有新型结合表位和对多种人ifn-α 亚型具有优异中和活性的全人单克隆抗体: 系统性红斑狼疮的候选疗法

IF7.3

2015-06-054

OAAI

Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor

ACTA PHARMACOLOGICA SINICA

IF8.4

2014-10-274

OAAI

Increasing stability of antibody via antibody engineering: Stability engineering on an anti-hVEGF

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

IF2.8

2014-07-0511

PREAI